Guangzhou, China – May 10, 2010 -- China Medicine Corporation (OTCBB: CHME) is a developer, manufacturer and leading distributor in China of Western pharmaceuticals, traditional Chinese medicine products, other nutraceuticals, medical devices, and medical formulations, today announced that it will conduct a conference call at 9:00 a.m. Eastern Time on Thursday, May 13, 2010 to discuss its first quarter 2010 results.
Joining Mr. Senshan Yang, Chairman and Chief Executive Officer of China Medicine Corporation, will be Mr. Fred Cheung, Chief Financial Officer. The Company plans to issues its earnings release prior to the call.
To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 1-800-688-0796. International callers should dial 1-617-614-4070, Conference Passcode: 10924041.
If you are unable to participate in the call at this time, a replay will be available for 14 days starting on Thursday, May 13, at 11:00 p.m. Eastern Time. To access the replay, dial 1-888-286-8010, international callers dial 1-617-801-6888, and enter the passcode of 97174060.
About China Medicine Corporation
China Medicine Corporation, a comprehensive enterprise with a research and development centre, manufacturing facilities and well established sales network, engages in the production and distribution of prescription and over the counter ("OTC") drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The Company distributes its products to wholesale distributors, including more than 300 hospitals and 500 medicine companies that sell to over 2,000 drug stores in 28 provinces throughout China. The Company is developing a number of proprietary products for a variety of uses, including oncology, high blood pressure and the removal of toxins from food and animal feeds.